Editas Medicine (EDIT) Non Operating Income (2015 - 2025)
Editas Medicine (EDIT) reported Non Operating Income of -$569000.0 for Q3 2025, down 11280.0% year-over-year from N/an in Q3 2024, and up 67.63% quarter-over-quarter from -$1.8 million in Q2 2025.
Editas Medicine (EDIT) Non Operating Income (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Non Operating Income data on file, last reported at -$569000.0 in Q3 2025.
- Non Operating Income for Q3 2025 came in at -$569000.0, down 11280.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $11.3 million (up 164.0% YoY), and the FY2024 annual result was $14.1 million, up 976.5% from the prior year.
- Non Operating Income grew to -$569000.0 in Q3 2025 per EDIT's latest filing, from -$1.8 million in the prior quarter.
- Over five years, Non Operating Income peaked at $14.1 million in Q4 2024 and troughed at -$1.8 million in Q2 2025.
- A 5-year average of $1.4 million and a median of $6000.0 in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2025: Non Operating Income jumped 514300.0% in 2023, then sank 11280.0% in 2025.
- A 5-year view of Non Operating Income shows it stood at -$433000.0 in 2021, then soared by 99.08% to -$4000.0 in 2022, then slumped by 250.0% to -$14000.0 in 2023, then soared by 100521.43% to $14.1 million in 2024, then slumped by 104.05% to -$569000.0 in 2025.
- Business Quant data shows EDIT's Non Operating Income at -$569000.0 in Q3 2025, -$1.8 million in Q2 2025, and -$425000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Editas Medicine | 262.77 Mn | 262.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -569,000.00 |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | -425,000.00 |
| Dec 31, 2024 | 14.06 Mn |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | 4.30 Mn |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | 5.14 Mn |
| Jun 30, 2023 | 3.80 Mn |
| Mar 31, 2023 | 1.93 Mn |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 781,000.00 |
| Mar 31, 2022 | -234,000.00 |
| Dec 31, 2021 | -433,000.00 |
| Sep 30, 2021 | 171,000.00 |
| Jun 30, 2021 | 145,000.00 |
| Mar 31, 2021 | 155,000.00 |
| Dec 31, 2020 | 3.38 Mn |